GTC and Laureate Pharma L.P. have entered a strategic collaboration to provide clients with a wide range of for recombinant protein production services from small scale through tonnage quantities. GTC and Laureate also offer process design and development, in addition to downstream purification, for initial clinical material through commercial launch in accordance with the standards set by good manufacturing practices. In addition, GTC and Laureate offer process design and development services to take a client's product from early stage laboratory work through to commercial sales. GTC and Laureate provide unique advantages in large volume as well as difficult-to-express protein production needs.
TransOva Genetics GTC contracts TransOva Genetics to produce transgenic cows expressing human serum albumin (hSA) in their milk. GTC and its partner, Fresenius AG, are developing a recombinant form of hSA as an alternative to product currently derived from human blood plasma. TransOva is an internationally recognized leader in embryo transfer services for cattle.
Invitrogen ( http://www.invitrogen.com/content.cfm?pageid=1 ) Invitrogen, in conjunction with GTC, is manufacturing, marketing, and distributing GTC's patented transgenic expression system, called the pBC1 kit, that allows researchers working in their own laboratories to insert a gene of interest in the DNA of a fertilized mouse ovum to produce selected therapeutics via transgenic technology in mouse milk.